Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Tickers
AGLE
ALPN
BCYC
BTAI
Tags
VCNX
AGLE
NVS
From
Benzinga
3 Things About Pfizer That Smart Investors Know
April 08, 2022
Tickers
ABBV
AZN
BMY
GSK
Tags
AZN
Market News
MRK
From
Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
Penny Stocks
PFE
GILD
From
InvestorPlace
Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication
April 06, 2022
Tickers
NVS
Tags
News
General
Health Care
From
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
News
Market News
RLMD
From
Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
Tags
Briefs
NVS
Biotech
From
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
IBB
General
VRDN
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
BPMC
PFE
SPY
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
April 04, 2022
Tickers
AAPL
CRRFY
FRCOY
MMM
Tags
$ETH
TWTR
Top Stories
From
Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
Tags
Market News
Biotech
NVS
From
Benzinga
3 CEOs to Invest In
April 01, 2022
Tickers
ANTM
AXSM
AZN
GH
Tags
GH
JAZZ
ANTM
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
BHVN
Trading Ideas
News
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
DCPH
WB
HCM
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
TCDA
Benzinga
CYCC
From
Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
March 27, 2022
Tickers
AZN
GRFS
GSK
JNJ
Tags
PFE
NVAX
ROG
From
Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
Tags
Health Care
European Medicines Agency
Benzinga
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
NVS
Recent Press Releases
INCY
From
Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
AMGN
NVS
Can/Fite BioPharma Ltd/
From
Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
Tags
Benzinga
Health Care
General
From
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
DGX
ATHA
Penny Stocks
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
Small Cap
NVS
LNTH
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
PFE
ANAB
News
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
$ETH
GS
Benzinga
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
Benzinga
Health Care
General
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
AMC
GSK
COMP
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
Market News
PFE
NVS
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
Market News
RHHBY
NVS
From
Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
March 14, 2022
Tickers
NVS
Tags
Biotech
Benzinga
General
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
Health Care
BIIB
Benzinga
From
Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
March 14, 2022
Tickers
CING
JNJ
NVS
Tags
CING
JNJ
NVS
From
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.